MicrobiologybioRxiv
Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2
J. Campagna, B. Jagodzinska, P. Alvarez…·V. John
The paper identifies eltrombopag as a PLpro inhibitor that can be repurposed for SARS-CoV-2 treatment, effective in combination with Mpro inhibitors.
DOI 10.26502/acbr.50170312